Why Is HIMS & HERS HEALTH I A (HIMS) Stock Up Today?

HIMS stock is up 5.68% to $30.33 in a volatile session driven by a surge in investor interest amid ongoing legal developments and potential short-term market positioning. The stock opened at $28.75 and climbed to a session high of $30.62 at 10:15 AM ET, with volume reaching 3.2 million shares, well above the 3-month average. The move comes amid a flurry of legal notices from law firms encouraging investors to pursue class-action lawsuits over alleged deceptive billing and privacy practices.

What Happened

Five news stories have emerged in the last 36 hours from two sources, all related to legal actions against Hims & Hers Health. These include notices from Wolf Haldenstein, Kahn Swick & Foti, and multiple statements from Rosen Law Firm and Kaplan Fox Kilsheimer LLP urging shareholders to seek legal counsel. These developments have drawn attention to the stock, particularly with the lead plaintiff deadline set for November 2, 2026. The increased visibility appears to have spurred a wave of retail and institutional buying, especially as the stock remains well below its 52-week high of $65.30.

What The Data Shows

The stock has risen 1.5% over the past eight sessions, from $27.99 to $28.42, but remains unprofitable with an EPS of -0.62 and a net margin of -5.5%. Despite a 28% year-to-date revenue increase, the company’s beta of 2.41 suggests significant volatility. Notably, insider transactions in the last 90 days include 12 sales totaling $6.1 million, with the most recent filing on September 23. The 52-week tape also shows 13 fresh 52-week highs and three fresh 52-week lows on September 30, indicating a mixed retail sentiment.

What To Watch

The stock is set for continued legal scrutiny and potential volatility. Investors should monitor the lead plaintiff deadline on November 2, 2026, as well as any updates from ongoing class-action lawsuits. Coverage breadth and potential earnings updates could also influence the stock’s direction in the coming weeks.